DexCom Inc (DXCM) — Capital Reinvestment Ratio
DexCom Inc (DXCM) has a Capital Reinvestment Ratio of 0.15x as of March 2026, meaning it reinvests 0% of its operating cash flow ($525.60 Million) in capital expenditures ($76.60 Million). Check DXCM tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
DexCom Inc Capital Reinvestment Ratio (2013–2025)
This chart tracks DexCom Inc's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see how efficiently does DexCom Inc generate cash.
Annual Capital Reinvestment Ratio for DexCom Inc (2013–2025)
Year-by-year Capital Reinvestment Ratio for DexCom Inc from 2013 to 2025. See how much free cash does DexCom Inc generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | $1.44 Billion | $363.50 Million | ▼ -30.4% |
| 2024 | 0.36x | $989.50 Million | $358.80 Million | ▲ +14.7% |
| 2023 | 0.32x | $748.50 Million | $236.60 Million | ▼ -42.0% |
| 2022 | 0.54x | $669.50 Million | $364.80 Million | ▼ -38.0% |
| 2021 | 0.88x | $442.50 Million | $389.20 Million | ▲ +110.2% |
| 2020 | 0.42x | $475.60 Million | $199.00 Million | ▼ -26.9% |
| 2019 | 0.57x | $314.50 Million | $180.00 Million | ▲ +5.1% |
| 2018 | 0.54x | $123.20 Million | $67.10 Million | ▼ -24.1% |
| 2017 | 0.72x | $92.00 Million | $66.00 Million | ▼ -27.6% |
| 2016 | 0.99x | $56.20 Million | $55.70 Million | ▲ +45.8% |
| 2015 | 0.68x | $49.00 Million | $33.30 Million | ▼ -1.0% |
| 2014 | 0.69x | $23.60 Million | $16.20 Million | ▼ -79.1% |
| 2013 | 3.29x | $2.40 Million | $7.90 Million | — |